BioLife Solutions (BLFS) Given a $8.00 Price Target at Maxim Group

Maxim Group set a $8.00 price objective on BioLife Solutions (NASDAQ:BLFS) in a research note released on Thursday morning. The brokerage currently has a buy rating on the medical equipment provider’s stock.

BioLife Solutions (NASDAQ BLFS) traded up $0.04 during trading on Thursday, hitting $5.89. 103,300 shares of the stock traded hands, compared to its average volume of 82,200. BioLife Solutions has a twelve month low of $1.62 and a twelve month high of $7.53. The stock has a market cap of $81.51, a PE ratio of -14.02 and a beta of 0.27.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative net margin of 52.10% and a negative return on equity of 49.92%. The business had revenue of $2.96 million during the quarter, compared to analysts’ expectations of $2.60 million. analysts forecast that BioLife Solutions will post -0.23 earnings per share for the current year.

Several institutional investors have recently bought and sold shares of the company. Essex Investment Management Co. LLC purchased a new stake in shares of BioLife Solutions in the 3rd quarter valued at approximately $484,000. EAM Investors LLC purchased a new position in shares of BioLife Solutions during the 3rd quarter worth approximately $555,000. Finally, Granite Investment Partners LLC purchased a new position in shares of BioLife Solutions during the 3rd quarter worth approximately $1,205,000. 9.41% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “BioLife Solutions (BLFS) Given a $8.00 Price Target at Maxim Group” was first published by Transcript Daily and is the property of of Transcript Daily. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at

BioLife Solutions Company Profile

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with's FREE daily email newsletter.

Leave a Reply